Citations

Clear

25 citation(s) found for "Lee, Wendy".

P1‐325: Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging Biomarkers
Stonnington, Cynthia M. , Lee, Wendy , Bauer, Robert, Sharieff, Sameen, Chen, Yinghua , Caselli, Richard J. , Reiman, Eric M. , Locke, Dona E.C. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2016.06.1076 Get It

P4‐149: Peripheral Apoe Levels are Associated with Regional Gray Matter Volume, Cerebral Glucose Metabolism and Cognitive Performance in Cognitively Normal APOE E3/4 Carriers
Lee, Wendy , Chen, Yinghua , Reiman, Eric M. , Caselli, Richard J. , Nielsen, Henrietta M. , Chen, Kewei , Chen, Yinghua, Bu, Guojun

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_22 | Pages: No page available

10.1016/j.jalz.2016.06.2240 Get It

P4‐298: IMPROVING THE POWER TO TRACK FIBRILLAR AMYLOID PET MEASUREMENTS AND EVALUATE AMYLOID‐MODIFYING TREATMENTS USING A CEREBRAL WHITE MATTER REFERENCE REGION‐OF‐INTEREST
Roontiva, Auttawut, Lee, Wendy , Ayutyanont, Napatkamon , Protas, Hillary , Landau, Susan , Luo, Ji , Bauer, Robert, Reschke, Cole, Bandy, Dan, Fleisher, Adam , Caselli, Richard J., Jagust, William J. , Weiner, Michael W. , Reiman, Eric M. , Chen, Kewei , Thiyyagura, Pradeep , Liu, Xiaofen , Koeppe, Robert A. , Caselli, Richard J.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2014.07.069 Get It

DT‐01–06: Baseline FDG‐PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study
Stonnington, Cynthia M. , Ayutyanont, Napatkamon , Reschke, Cole, Thyyagura, Pradeep, Protas, Hillary , Roontiva, Auttawut, Parks, Stephanie, Bauer, Robert, Lee, Wendy , Jagust, William, Foster, Norman L. , Weiner, Michael W. , Fleisher, Adam , Reiman, Eric M. , Chen, Kewei , Liu, Xiaofen , Koeppe, Robert A.

Mayo Clinic

Alzheimer's & Dementia | October 9, 2013 | Volume: 9 | Issue: 4S_Part_21 | Pages: No page available

10.1016/j.jalz.2013.08.007 Get It

Fibrillar amyloid correlates of preclinical cognitive decline
Stonnington, Cynthia M. , Chen, Kewei , Lee, Wendy , Locke, Dona E.C. , Dueck, Amylou C., Roontiva, Auttawut, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Dueck, Amylou C. , Liu, Xiaofen , Dueck, A. C. , Locke, Dona E C

Mayo Clinic

Alzheimer's & Dementia | April 16, 2013 | Volume: 10 | Issue: 1 | Pages: No page available

10.1016/j.jalz.2013.01.009 | PMID 23583233 Get It

AbstractBackgroundIt is not known whether preclinical cognitive decline is associated with fibrillar β‐amyloid (Aβ) deposition irrespective of apolipoprotein E (APOE) ε4 status.MethodsFrom a prospective observational study of 623 cognitively normal individuals, we identified all subjects who showed preclinical decline of at least 2 standard deviations beyond the decline of the entire group in memory or executive function. Fourteen decliners were matched by APOE ε4 gene dose, age, sex, and education with 14 nondecliners. Dynamic Pittsburgh compound B (PiB) positron emission tomography (PET) scans, the Logan method, statistical parametric mapping, and automatically labeled regions of interest were used to characterize and compare cerebral‐to‐cerebellar PiB distribution volume ratios (DVRs), reflecting fibrillar Aβ burden.ResultsAt P < .005 (uncorrected), decliners had significantly greater DVRs in comparison to nondecliners.ConclusionsAsymptomatic longitudinal neuropsychological decline is associated with subsequent increased fibrillar amyloid deposition, even when controlling for APOE ε4 genotype.
Subjective cognitive decline: Self and informant comparisons
Caselli, Richard J. , Chen, Kewei , Locke, Dona E.C. , Lee, Wendy , Roontiva, Auttawut, Bandy, Dan, Fleisher, Adam , Reiman, Eric M. , Locke, Dona E C

Mayo Clinic

Alzheimer's & Dementia | April 4, 2013 | Volume: 10 | Issue: 1 | Pages: 93-98

10.1016/j.jalz.2013.01.003 | PMID 23562429 Get It

AbstractBackgroundIt is unclear whether self‐ or informant‐based subjective cognition better distinguishes emotional factors from early‐stage Alzheimer's disease (AD).MethodsHealthy members (n = 447) of the Arizona apolipoprotein E (APOE) cohort and their informants completed the self and informant paired Multidimensional Assessment of Neurodegenerative Symptoms questionnaire (MANS).ResultsDecline on the MANS was endorsed by 30.6% of members and 26.2% of informants. Self‐ and informant‐based decliners had higher scores of psychological distress and slightly lower cognitive scores than nondecliners. Over the next 6.7 years, 20 developed mild cognitive impairment (MCI). Converters were older at entry than nonconverters (63.8 [7.0] vs 58.8 [7.3] years, P = .003), 85% were APOE ε4 carriers (P < .0001), and they self‐endorsed decline earlier than informants (58.9 [39.2] vs 28.0 [40.4] months before MCI; P = .002).ConclusionsSelf‐ and informant‐based subjective decline correlated with greater psychological distress and slightly lower cognitive performance. Those with incident MCI generally self‐endorsed decline earlier than informants.
Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions
Burns, Christine , Chen, Kewei , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M.

Mayo Clinic

Neurology | March 28, 2013 | Volume: 80 | Issue: 17 | Pages: 1557-1564

10.1212/wnl.0b013e31828f17de | PMID 23535495 Get It

O2‐06‐04: Impact of different PET image quantification methods, regions‐of‐interest and risk factors on the power to detect a slowing in beta‐amyloid deposition in presymptomatic Alzheimer's disease trials
Fleisher, Adam , Roontiva, Auttawut, Lee, Wendy , Esque, Jacquelin, Bandy, Dan, Caselli, Richard J., Reiman, Eric M. , Liu, Xiaofen , Chen, Kewei , Thiyyagura, Pradeep

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2012.05.657 Get It

P2‐191: Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease
Burns, Christine , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Daniel, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | January 12, 2012 | Volume: 7 | Issue: 4S_Part_24 | Pages: No page available

10.1016/j.jalz.2011.09.024 Get It

IC‐P‐086: Investigating the association between fasting serum glucose levels and cerebral metabolic rate for glucose in brain regions affected by Alzheimer's disease
Burns, Christine , Kaszniak, Alfred W., Lee, Wendy , Alexander, Gene E. , Bandy, Dan, Fleisher, Adam , Caselli, Richard J. , Reiman, Eric M. , Chen, Kewei

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2011.05.152 Get It